Chapter 16. CRS+HIPEC in Epithelial Ovarian Cancer (EOC) with peritoneal dissemination

VIDEOS 16: CRS+HIPEC in Epithelial Ovarian Cancer (EOC) with peritoneal dissemination

CRS+HIPEC in Epithelial Ovarian Cancer (I):

16.1: CRS+HIPEC: FIGO IIIB epithelial ovarian cancer

16.2: CRS+HIPEC: FIGO IIIC epithelial ovarian cancer

16.3: CRS+HIPEC: epithelial ovarian cancer FIGO IV

16.4: CRS+HIPEC: peritoneal recurrence of ovarian cancer

16.5: Primary surgical treatment of advanced borderline ovarian cancer

CRS+HIPEC in other gynecological tumors(II):

16.6: CRS+HIPEC: peritoneal recurrence of borderline ovarian cancer

16.7: CRS+HIPEC in endometrial cancer recurrence (surgery and previous RDT)

16.8: CRS+HIPEC in primary peritoneal cancer recurrence

16.9: CRS+HIPEC in recurrence of endocervical mucinous adenocarcinoma

16.10: CRS+HIPEC in uterine sarcoma

16.11: CRS+HIPEC in the recurrence of immature teratoma (G2)